PortfoliosLab logoPortfoliosLab logo
GERM vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GERM vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*

XLVI

1D
0.67%
1M
2.30%
YTD
-0.67%
6M
0.76%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. XLVI - Yearly Performance Comparison


GERM vs. XLVI - Sectors Allocation Comparison


Sectors
GERM
XLVI

Healthcare

99.3%

-

Financial Services

0.4%
100.6%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

GERM
99.3%
XLVI

-

Financial Services

GERM
0.4%
XLVI
100.6%

Basic Materials

GERM

-

XLVI

-

Communication Services

GERM

-

XLVI

-

Consumer Cyclical

GERM

-

XLVI

-

Consumer Defensive

GERM

-

XLVI

-

Energy

GERM

-

XLVI

-

Industrials

GERM

-

XLVI

-

Real Estate

GERM

-

XLVI

-

Technology

GERM

-

XLVI

-

Utilities

GERM

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GERM vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GERM vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GERMXLVIDifference

Sharpe Ratio (All Time)

Calculated using the full available price history

1.33

Drawdowns

GERM vs. XLVI - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum XLVI drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for GERM and XLVI.


Loading charts...

Drawdown Indicators


GERMXLVIDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-8.14%

+8.14%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

Current Drawdown

Current decline from peak

0.00%

-4.02%

+4.02%

Average Drawdown

Average peak-to-trough decline

0.00%

-1.95%

+1.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

Volatility

GERM vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


GERMXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

10.94%

-10.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

10.94%

-10.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

10.94%

-10.94%

GERM vs. XLVI - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

GERM vs. XLVI - Dividend Comparison

GERM has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.53%.


Frequently Asked Questions


On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.

XLVI has the higher dividend yield at 11.53%, compared with 0.00% for GERM.

GERM is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Amplify and State Street. Their fees differ too: 0.68% for GERM and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for GERM and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer